This new study was published online yesterday in the prestigious British Medical Journal (BMJ).
COPD is a chronic lung disease that affects over 200 million people worldwide.
It is estimated up to one in six people over the age of 45 are living with COPD and it is now the fourth largest killer of Australians.
COPD is a chronic lung disease characterised by partial obstruction in the airway tubes which results in breathing difficulties. It is a progressive, disabling and potentially fatal disease.
Unlike asthma, COPD is not reversible with medications and it is most commonly found in people who have smoked cigarettes or been exposed to airborne irritants.
Menzies’ researchers have found the risk of death in patients with COPD was significantly reduced by using controlled oxygen therapy instead of the standard approach of high concentration levels of oxygen.
Senior author and co-investigator of the paper, Menzies’ Honorary Member, Associate Professor Wood-Baker says that high concentration oxygen is currently used routinely in Australia by many paramedics in emergency situations for patients with acute breathlessness caused by episodes of COPD.
“Giving high concentration oxygen to patients with COPD, however, can lead to a build up of carbon dioxide in the blood, which can lead to respiratory failure,” Associate Professor Wood-Baker said.
The study involved 405 patients aged 35 years and over who were treated by 62 paramedics from the Tasmanian Ambulance Service and transported to a local hospital.
Overall, controlled oxygen therapy reduced the risk of death from respiratory failure by 58 per cent for all patients and 78 per cent for confirmed COPD patients compared to high concentration oxygen therapy.
First author and chief investigator, Dr Mike Austin, says the findings provide the first high quality evidence from a randomised controlled trial for the development of new universal guidelines on oxygen therapy for patients with chronic lung disease.
This research supports the British Thoracic Society’s 2008 guidelines on acute oxygen treatment* which recommends oxygen should be administered only at levels sufficient to maintain adequate oxygen saturations,” Dr Austin said.
“These guidelines where implemented by the UK ambulance service in 2009.”
“Oxygen therapy should only be given in specific circumstances in which the benefits outweigh the risks, and the patient’s response to the therapy must be closely monitored,” he said.
Funding bodies that supported this COPD research include the Australian College of Ambulance Professionals (ACAP). Walkie nebulization air compressors were donated by FlaemNova, Milan, Italy.
*The British Thoracic Society together with 21 other UK Colleges and Societies produced a guideline in 2008 recommending oxygen therapy for patients with COPD should be controlled to achieve a blood oxygen saturation of 88-92 per cent compared with the standard oxygen saturation range of 94-98 per cent that is largely used for most other medical emergencies.
For more information contact: Fiona Horwood, Communications Manager, Menzies Research Institute
p 03 6226 7751 or visit www.menzies.utas.edu.au